Sign In
Buy NEPH
$3.39
-0.110 (-3.14%)
At Close: Jul 31, 2026
OraSure Technologies (OSUR) in Focus: Stock Moves 7.6% Higher
01:35pm, Thursday, 02'nd Apr 2020
OraSure Technologies (OSUR) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
OraSure Technologies (OSUR) in Focus: Stock Moves 7.6% Higher
01:35pm, Thursday, 02'nd Apr 2020
OraSure Technologies (OSUR) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Nephros Announces Preliminary Financial Results for First Quarter 2020
11:30am, Thursday, 02'nd Apr 2020
Anticipates $2.6 Million Net Revenues, Approximately 45% Growth Over 2019 SOUTH ORANGE, NJ, April 02, 2020 -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a.
Abbott (ABT) in Focus: Stock Moves 6.4% Higher
02:20pm, Tuesday, 31'st Mar 2020
Abbott (ABT) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Abbott (ABT) in Focus: Stock Moves 6.4% Higher
02:20pm, Tuesday, 31'st Mar 2020
Abbott (ABT) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Specialty Renal Products Announces Appointment of Tony Robinson as Vice President of Operations
11:30am, Wednesday, 25'th Mar 2020
SOUTH ORANGE, NJ, March 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Specialty Renal Products, Inc. (SRP), a subsidiary of Nephros, Inc. (NEPH), a medical device company that develops and sells
Agios' IND for PKR Activator AG-946 Gets FDA Clearance
05:08pm, Tuesday, 24'th Mar 2020
The FDA passes Agios' (AGIO) investigational new drug application for its next-generation PKR activator, AG-946. The company plans to begin a phase I study on the same in mid-2020.
Agios' IND for PKR Activator AG-946 Gets FDA Clearance
05:08pm, Tuesday, 24'th Mar 2020
The FDA passes Agios' (AGIO) investigational new drug application for its next-generation PKR activator, AG-946. The company plans to begin a phase I study on the same in mid-2020.
Read This Before Selling Nephros, Inc. (NASDAQ:NEPH) Shares
12:54pm, Thursday, 19'th Mar 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
Nephros to Present at the Sidoti Spring 2020 Investor Conference
11:30am, Tuesday, 10'th Mar 2020
SOUTH ORANGE, NJ, March 10, 2020 -- via NEWMEDIAWIRE -- Nephros, Inc.(Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification.
Analyzing Nephros (OTCMKTS:NEPH) and ABIOMED (OTCMKTS:ABMD)
07:38am, Sunday, 08'th Mar 2020
Nephros (OTCMKTS:NEPH) and ABIOMED (NASDAQ:ABMD) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, ea
Nephros, Inc to Present at the Spring Investor Summit on March 25th-26th in New York City
09:45pm, Wednesday, 04'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 4, 2020 / Nephros, Inc (Nasdaq:NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems t
Nephros to Present at the 2020 LD Micro Virtual Conference
12:30pm, Tuesday, 03'rd Mar 2020
LOS ANGELES, CA / ACCESSWIRE / March 3, 2020 / Nephros, Inc. (Nasdaq:NEPH), a commercial stage company that develops and sells high performance water purification products and pathogen detection syste
Nephros Reports 2019 Fourth Quarter and Full Year Financial Results
09:05pm, Thursday, 27'th Feb 2020
Fourth Quarter Net Revenue up 96%; Annual Net Revenue up 82%Establishes 2020 Revenue Guidance at $14.5 to $15.5 Million SOUTH ORANGE, N.J., Feb. 27, 2020 -- Nephros, Inc..
What format should I store my ECG data in for DL training?
06:51pm, Monday, 24'th Feb 2020
A case study of optimizing ECG data layout to improve deep learning training performance.
